Inventor · disambiguated record
Tamie J. Chilcote
Also filed as: CHILCOTE TAMIE · CHILCOTE TAMIE J · CHILCOTE TAMIE JO
22 granted patents·14 pending applications·359 citations·filing 2004–2024
96Inventor score
Files withELAN PHARM INC9PROTHENA BIOSCIENCES LTD6SCHENK DALE B5REZOLUTE INC4ACTIVESITE PHARMACEUTICALS INC3
Top patents by PatentIndex Score
36 records- 0198US7910333B2Antibodies to alpha-synucleinELAN PHARM INC·Filed 2010·Granted Mar 22, 2011·52 cites·9 claims
- 0296US7674599B2Methods of using antibodies to detect alpha-synuclein in fluid samplesELAN PHARM INC·Filed 2004·Granted Mar 9, 2010·49 cites·11 claims
- 0395US7358331B2Truncated fragments of alpha-synuclein in Lewy body diseaseELAN PHARM INC·Filed 2005·Granted Apr 15, 2008·43 cites·11 claims
- 0494US8092801B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Jan 10, 2012·44 cites·15 claims
- 0594US7919088B2Treatment and delay of onset of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2007·Granted Apr 5, 2011·40 cites·15 claims
- 0693US8147833B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Apr 3, 2012·18 cites·4 claims
- 0793US7625944B2Inhibitors of plasma kallikreinACTIVESITE PHARMACEUTICALS INC·Filed 2007·Granted Dec 1, 2009·29 cites·33 claims
- 0891US8673593B2Antibodies to alpha-synucleinCHILCOTE TAMIE·Filed 2011·Granted Mar 18, 2014·14 cites·8 claims
- 0991US8506959B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2005·Granted Aug 13, 2013·13 cites·15 claims
- 1084US7306945B2Truncated fragments of alpha-synuclein in Lewy body diseaseELAN PHARM INC·Filed 2004·Granted Dec 11, 2007·30 cites·11 claims
- 1183US9034337B2Treatment and delay of outset of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2007·Granted May 19, 2015·7 cites·15 claims
- 1283US8258170B2Inhibitors of plasma kallikreinSINHA SUKANTO·Filed 2011·Granted Sep 4, 2012·6 cites·12 claims
- 1383US7977380B2Inhibitors of plasma kallikreinACTIVESITE PHARMACEUTICALS INC·Filed 2009·Granted Jul 12, 2011·5 cites·7 claims
- 1481US11306061B2Crystalline forms of plasma kallikrein inhibitorsREZOLUTE INC·Filed 2020·Granted Apr 19, 2022·1 cites·6 claims
- 1573US8658685B2Methods for treatment of kallikrein-related disordersAIELLO LLOYD P·Filed 2009·Granted Feb 25, 2014·5 cites·24 claims
- 1670US2021032318A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 1768US12240818B2Crystalline forms of plasma kallikrein inhibitorsREZOLUTE INC·Filed 2022·Granted Mar 4, 2025·0 cites·11 claims
- 1868US2024254211A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 1966US9879071B2Antibodies to alpha synucleinCHILCOTE TAMIE J·Filed 2012·Granted Jan 30, 2018·1 cites·5 claims
- 2066US8691861B2Prodrugs of inhibitors of plasma kallikreinSINHA SUKANTO·Filed 2012·Granted Apr 8, 2014·2 cites·31 claims
- 2166US2019300598A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 2263US2009035217A1Truncated Fragments of Alpha-Synuclein in Lewy Body DiseaseELAN PHARM INC·Filed 2008·Application pending·0 cites
- 2362US2017349651A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2017·Application pending·0 cites
- 2461US2018355028A1Antibodies to Alpha SynucleinPROTHENA BIOSCIENCES LTD·Filed 2018·Application pending·0 cites
- 2561US2023234927A1Processes for preparing plasma kallikrein inhibitorsREZOLUTE INC·Filed 2022·Application pending·0 cites
- 2660US11267790B2Processes for preparing plasma kallikrein inhibitorsREZOLUTE INC·Filed 2020·Granted Mar 8, 2022·0 cites·20 claims
- 2759US2012201842A1Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2012·Application pending·0 cites
- 2858US2017204173A1Antibodies to Alpha SynucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Application pending·0 cites
- 2955US2008300206A1Alpha-Synuclein KinaseELAN PHARM INC·Filed 2008·Application pending·0 cites
- 3053US9206123B2Prodrugs of inhibitors of plasma kallikreinACTIVESITE PHARMACEUTICALS INC·Filed 2013·Granted Dec 8, 2015·0 cites·11 claims
- 3153US2008014194A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseELAN PHARM INC·Filed 2007·Application pending·0 cites
- 3253US2009215080A1Methods for identification of inhibitors of enzyme activityACTIVESITE PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 3350US2010031377A1Prevention and treatment of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2005·Application pending·0 cites
- 3446US2011207796A1Alpha-synuclein kinaseELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 3538US8609866B2Prodrugs of inhibitors of plasma kallikreinSINHA SUKANTO·Filed 2010·Granted Dec 17, 2013·0 cites·9 claims
- 3638US8148089B2Alpha-synuclein kinaseANDERSON JOHN P·Filed 2010·Granted Apr 3, 2012·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →